IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 47 filers reported holding IKENA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,239,808 | -26.9% | 517,216 | +10.7% | 0.00% | – |
| Q2 2023 | $3,064,825 | +266.0% | 467,199 | +92.5% | 0.00% | – |
| Q1 2023 | $837,384 | +133241.4% | 242,720 | +2.7% | 0.00% | – |
| Q4 2022 | $628 | -99.9% | 236,434 | -0.2% | 0.00% | – |
| Q3 2022 | $841,000 | +85.2% | 236,948 | +130.8% | 0.00% | – |
| Q2 2022 | $454,000 | -77.4% | 102,674 | -68.8% | 0.00% | – |
| Q1 2022 | $2,006,000 | -43.8% | 329,003 | +15.7% | 0.00% | – |
| Q4 2021 | $3,567,000 | +45.4% | 284,454 | +46.3% | 0.00% | – |
| Q3 2021 | $2,454,000 | +49.1% | 194,461 | +65.9% | 0.00% | – |
| Q2 2021 | $1,646,000 | – | 117,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |